Skip to main content
MedicineWatch US
Explore records
Trends
Coverage
About
Methodology
Report an issue
Privacy
Samsung Bioepis Co., Ltd.
Provisional
Yeonsu · korea (the republic of)
1 recall flag(s)
FDA Flags (1)
Class II Recall
Nov 2025
Samsung Bioepis Co., Ltd.
HADLIMA (adalimumab-bwwd) injection, 40mg/0.8 mL, 2 Single-dose Prefilled Syringes per carton, Rx only, Manufactured for
Classification: Class II
Samsung Bioepis Co., Ltd. | MedicineWatch US